More Stories

Oculogica Publishes 5-Site Study on Its FDA-Cleared Concussion Diagnostic


NEW YORK, February 6, 2023 (Newswire.com)
–
Oculogica Inc. announces publication of the initial five-site study performed to obtain FDA Marketing Authorization for its EyeBOX technology as an aid in the diagnosis of concussion. EyeBOX uses eye tracking to assess pupil size and position to determine whether a person has sustained damage to brain regions that control those functions.

The study, published in Frontiers in Neurology Dec. 1, 2022, was performed on 282 emergency room or concussion clinic patients ages 5 to 67 within two weeks of injury. Study participants were evaluated at New York City’s Bellevue Hospital, Rochester’s Mayo Clinic, Pittsburgh’s Allegheny Hospital, Denver’s Rocky Mountain Hospital for Children, and Beaver Dam Wisconsin’s Community Hospital.

The study demonstrated that patients who had symptoms of concussion and scored poorly on a cognition assessment were more likely to have abnormal eye tracking, as assessed by the technology’s proprietary BOX (Brain injury associated Ocular motility dysfunction) Score. The BOX Score diagnosed concussion with over 80% sensitivity.

“The brain has tremendous heterogeneity of normal baseline function. This makes it challenging to figure out normal versus abnormal function when injury occurs. Assessment of pupil size and movement can be a powerful way to assess function because the majority of people have relatively normal function that is controlled reflexively. A person cannot pretend to have pupils that constrict normally and move in a synchronized way when they do not,” said neurosurgeon Uzma Samadani, MD, Ph.D., and Oculogica founder. “Similarly, if their brain and therefore pupil function is normal, it is difficult to pretend that it is not. Eye tracking to assess pupil size and position is a truly objective measure of physiologic brain function. We consider it a form of more precise digital neurologic examination. We believe that this will eventually and inevitably become standard of care.”

“We decided to publish this data because so many people have asked us what the gold-standard for concussion is, and how one obtains FDA approval for a concussion diagnostic,” said Oculogica CEO Rosina Samadani, Ph.D. “The reality is that there is currently no single gold-standard, and that is one of the challenges of any study in the field. We found that those with the worst symptoms and poorest cognition were most likely to have an elevated BOX score. Fundamentally, if a patient has abnormal eye reflexes or movement, that is their objective physiologic condition, regardless of symptom severity or ability to perform on a cognitive test. This information is helpful when people may under or over-report symptoms or have high or low baseline cognitive skills. It also may reduce biases due to language, culture, education or other factors that impact traditional patient assessment.”

The EyeBOX technology is the first non-invasive, non-baseline requiring concussion diagnostic approved by the FDA for aid in the diagnosis of concussion. Leading clinics, such as the Mayo Clinic, Midwest Orthopedics at Rush University and Minneapolis Clinic of Neurology, amongst others, offer the technology.

Contact Information:

Cady Roedl

Customer Success Manager

[email protected]

9205173873

Original Source:

Oculogica Publishes 5-Site Study on Its FDA-Cleared Concussion Diagnostic

Editor

Northwest Arkansas’ First Robotic Total Knee Arthroplasty in an ASC Performed by C. Kris Hanby, M.D., of Ozark Orthopaedics

The surgery is now offered in an ASC setting by all of Ozark Orthopaedics’ joint replacement specialists.


Dr. Hanby and His Team
Northwest Arkansas’ First Robotic Total Knee Arthroplasty in an ASC Performed by C. Kris Hanby, M.D., of Ozark Orthopaedics.


ROGERS, Ark., February 4, 2023 (Newswire.com)
–
Ozark Orthopaedics surgeon C. Kris Hanby, M.D., has officially performed the first robot-assisted Total Knee Arthroplasty in a Northwest Arkansas ASC with the Zimmer Biomet ROSA® Knee System. 

The procedure was performed Thursday, Jan. 19, 2023, at Precision Surgical Center of Northwest Arkansas.

“I’m excited about our ability to perform this procedure in an ASC setting. We’re the first to do it in Northwest Arkansas,” stated C. Kris Hanby, M.D., a board-certified orthopaedic surgeon and joint reconstruction specialist at Ozark Orthopaedics. “For many patients, ASCs offer an efficient and affordable outpatient experience with the same state-of-the-art technology and safety standards as a typical hospital setting.”

The surgery is now offered in the ASC by all of Ozark Orthopaedics’ joint replacement specialists. Dr. Jonathan D. Creech of Ozark Orthopaedics performed the surgery Thursday, Jan. 26, and Dr. Matthew J. Coker will perform the surgery in the coming weeks.

This procedure may be appropriate for anyone suffering from severe knee pain or stiffness resulting from noninflammatory degenerative joint disease (including osteoarthritis, traumatic arthritis, or avascular necrosis), rheumatoid arthritis, or post-traumatic arthritis and for whom conservative treatment options, like bracing, medication or joint fluid supplements, have not provided relief.

For more information, please visit Ozark-Ortho.com/contact-us.

ABOUT OZARK ORTHOPAEDICS 

Ozark Orthopaedics has been setting the standards for total orthopaedic care in Northwest Arkansas for 75 years. Our expert physicians and physical therapists treat injuries and problems of the spine, hand, wrist, elbow, shoulder, knee, hip, foot and ankle, as well as sports medicine concerns. For more information, visit Ozark-Ortho.com.  

ABOUT PRECISION SURGICAL CENTER OF NORTHWEST ARKANSAS 

The Precision Surgical Center of Northwest Arkansas, LLC was established in 2018 by hospital and clinical personnel to offer safe, high-quality surgical care. The center specializes in outpatient surgery, providing patients with personalized service and excellent medical care. The center meets the highest industry standards for top-quality healthcare and is accredited by The Joint Commission. For more information, visit PrecisionNWA.com.

Contact Information:

Michelle Haley

Director, Patient Services

[email protected]

(479) 521-2752

Original Source:

Northwest Arkansas’ First Robotic Total Knee Arthroplasty in an ASC Performed by C. Kris Hanby, M.D., of Ozark Orthopaedics

Editor